Table 1.

Demographic, clinical, and neuropathological characteristics of patient samples

CaseCountrySexAge at onset (y)Duration (y)Cause of deathClinical diagnosisNeuropathological diagnosis
C1USAM77NACardiovascular diseaseNondiseased control brainNA
PD1UKM658.5Tremulous hemiparkinsonism, REM sleep disorder, MSA questionedLewy body disease
PD2UKM658Myocardial infarction, acute renal failure, pneumoniaHemiparkinsonism with autonomic featuresLewy body disease
PD3*UKM669.5Parkinsonism with droolingLewy body disease
PD5AustraliaM639Myocardial infarctionParkinson’s diseaseParkinson’s disease
PD6AustraliaM736Myocardial infarctionParkinson’s diseaseDiffuse Lewy bodies
PD7AustraliaM748Cerebrovascular accidentParkinson’s diseaseDiffuse Lewy bodies
MSA1UKM788Atypical akinetic-rigid syndrome with prominent ataxia, PSP questionedMSA
MSA2UKM655.5Akinetic-rigid syndrome with autonomic involvementMSA
MSA3UKF526BronchopneumoniaMSA-PMSA
MSA4UKM687PneumoniaMSAMSA
MSA5UKM528Respiratory failure, pneumoniaParkinsonism, MSA questionedMSA
MSA6UKF4813PneumoniaAkinetic-rigid syndrome with antecolls and camptocormia: MSA vs. PDMSA
MSA7UKM5212BronchopneumoniaMSA-CMSA
MSA8AustraliaM574Aspiration pneumoniaMSA-PMSA
MSA9AustraliaM757Cardiorespiratory failureMSA-CMSA
MSA10AustraliaM568BronchopneumoniaMSA-P with early autonomic dysfunctionMSA
MSA11AustraliaM592Respiratory failureMSA-P with early autonomic dysfunctionMSA
MSA12USAF5511Acute bronchopneumoniaMSAMSA
MSA13USAM5510Chronic pneumoniaMSAMSA
MSA14USAM608MSA-CMSA
  • NA, not applicable.

  • * Clinical report for PD3 was incomplete.